---
title: "医疗保健行业因资金轮动进入滞后板块而上涨——医疗保健行业综述"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286822335.md"
description: "医疗公司获得了收益，因为交易者将注意力转向表现不佳的行业。然而，再生元制药在其用于黑色素瘤的 fianlimab 药物的晚期研究失败后，股价大幅下跌。此外，一名美国人在刚果民主共和国感染了埃博拉病毒，正值疫情持续爆发之际"
datetime: "2026-05-18T21:34:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286822335.md)
  - [en](https://longbridge.com/en/news/286822335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286822335.md)
---

# 医疗保健行业因资金轮动进入滞后板块而上涨——医疗保健行业综述

Health-care companies rose as traders rotated into some lagging sectors.

Regeneron Pharmaceuticals shares fell sharply in premarket trading Monday after the biotechnology company reported a late-stage study failure of its fianlimab drug candidate in the skin cancer melanoma.

An American contracted Ebola while working in the Democratic Republic of Congo, where the outbreak of the fatal virus is spreading.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

May 18, 2026 17:26 ET (21:26 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### 相关股票

- [REGN.US](https://longbridge.com/zh-CN/quote/REGN.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)

## 相关资讯与研究

- [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md)
- [定义 “医院 AI 操作系统”：北协和、南湘雅等顶级医院 为何集体选择医渡科技？](https://longbridge.com/zh-CN/news/286870257.md)
- [再生元制药因第三阶段黑色素瘤试验失败股价下跌 10%。那么，接下来 REGN 股票会如何表现呢？](https://longbridge.com/zh-CN/news/286811938.md)
- [“搞钱”，才是 Revolution 千亿神话密码](https://longbridge.com/zh-CN/news/286888792.md)
- [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md)